Healthcare, especially smaller practices, remains a prime target for hackers due to limited security resources. Pete Reilly from HUB International analyzes the cybersecurity risks these practices are expected to face by 2025.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
